Dexrazoxane for treating antitumor-induced cardiotoxicity

Details Dexrazoxane for treating antitumor-induced cardiotoxicity Dexrazoxane for treating antitumor-induced cardiotoxicity

A - Human Necessities

61

K

A61K 39/395 (2006.01) A61K 31/496 (2006.01) A61P 9/00 (2006.01) A61P 35/00 (2006.01) C07K 16/32 (2006.01)

Patent

CA 2467229

The present invention relates to a method for treating a cancer, which comprises administering a therapeutically effective amount of trastuzumab alone or in association with an anthracycline to a patient in need thereof, in combination with an amount of dexrazoxane effective to ameliorate cardiotoxicity.

L'invention concerne une méthode de traitement d'un cancer consistant à administrer une quantité efficace sur le plan thérapeutique de trastuzumab, seul ou associé à une anthracycline, de manière à traiter un patient nécessitant un tel traitement, conjointement avec une quantité de dexrazoxane permettant d'améliorer la cardiotoxicité.

Affiliated with

Also associated with

Rating

Dexrazoxane for treating antitumor-induced cardiotoxicity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dexrazoxane for treating antitumor-induced cardiotoxicity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dexrazoxane for treating antitumor-induced cardiotoxicity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1876011